Monash Ivf (MVF.AU)

Monash Ivf share price today, ATLAS forecast and fair value

Healthcare · Diagnostics & Research · Australian Securities Exchange · Australia

A$0.710▲ 0.00%

Prices as of Oct 27, 2026 · AUD

ATLAS fair value

A$0.379

Above fair value · 87% premium

Chance of rising in 1 month

50%

that it ends higher than today in 21 sessions

0%coin flip 50%100%

This is just the summary. See everything on Monash Ivf in ATLAS

ATLAS's own quantitative analysis, all in one place.

  • Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
  • Officers and shareholdersWho runs the company and which funds hold its shares.
  • Customer and supplier mapWho it does business with, from its own filings.
  • ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
  • AlertsWe let you know when something changes in your stocks.
See everything included
  • Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
  • NewsThe latest on the company, in one place.
  • Crisis simulatorHow your portfolio would do in a crash like 2008.
  • Practice risk-free$10,000 in virtual money to invest at real prices.
  • Global screenerSearch US stocks and stocks from 47 countries with filters.

On Monash Ivf

  • Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
  • Officers and shareholdersWho runs the company and which funds hold its shares.
  • Customer and supplier mapWho it does business with, from its own filings.
  • Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
  • NewsThe latest on the company, in one place.

And for you

  • ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
  • AlertsWe let you know when something changes in your stocks.
  • Crisis simulatorHow your portfolio would do in a crash like 2008.
  • Practice risk-free$10,000 in virtual money to invest at real prices.
  • Global screenerSearch US stocks and stocks from 47 countries with filters.
Get started →

Plans from €3.99 a month.

ATLAS estimates Monash Ivf's fair value at about A$0.379 per share (reasonable range: A$0.244 to A$0.589). At A$0.710, the stock trades 87% above it.

It is calculated with a blend of a discounted cash-flow model and peer valuation multiples. Confidence in the estimate is medium. It is an estimate, not a promise: if the company's results change, so does its fair value.

ATLAS's model gives Monash Ivf a 50% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.

In half of the simulated outcomes the price ends between A$0.663 and A$0.759; in 9 out of 10, between A$0.588 and A$0.857. Estimated annual volatility is 35%.

Price, last 12 months (weekly close)

Monash Ivf (MVF.AU) — Price, last 12 months (weekly close)Oct 24, 2025: A$0.720. Oct 27, 2026: A$0.710. ▼Fair value A$0.379A$0.850A$0.610Oct 24, 2025Oct 27, 2026

Key numbers

Market cap
A$280M
Market cap (USD)
$197M
P/E ratio
36.5
Dividend yield
3.52%
52-week high
A$0.895
52-week low
A$0.575
Revenue (12 months)
A$269M
Gross margin
28.5%
Operating margin
4.0%
Net margin
2.8%
Beta
0.34

What this means

These are two different questions: fair value looks at the business (what it is worth given what it earns) and the odds look at the price over the next month. Monash Ivf sits above fair value and its odds of rising over a month are close to a coin flip. An expensive stock can keep climbing and a cheap one can keep falling, which is why ATLAS shows the two readings separately.

Over the last 52 weeks MVF.AU has traded between A$0.575 and A$0.895. Today it is 20.7% below that high and 23% above its low.

On the business: net margin is 2.8%; it trades at 36.5 times earnings.

Its beta is 0.34: it tends to move less than the market.

About the company

Monash IVF Group Limited engages in the provision of assisted reproductive genetic and specialist women imaging services in Australia and Southeast Asia. It offers diagnostic obstetric, gynecological ultrasound, and fertility treatment services.

Want to see everything about Monash Ivf?

Get started →

Plans from €3.99 a month.

Comparable companies

Other companies in the same line of business:

Frequently asked questions

What is Monash Ivf (MVF.AU) fair value?

About A$0.379 per share according to ATLAS (reasonable range: A$0.244 to A$0.589). With the stock at A$0.710, it is 87% above it.

What is the chance MVF.AU goes up next month?

50%: close to a coin flip. In half of the simulated outcomes, MVF.AU ends the month between A$0.663 and A$0.759.

How big is Monash Ivf and what is its P/E ratio?

Monash Ivf's market capitalization is A$280M. Its price-to-earnings (P/E) ratio is 36.5: you pay A$36.5 for each A$1.00 of yearly earnings.

Does Monash Ivf pay a dividend?

Yes. MVF.AU's current dividend yield is 3.52% at today's price (A$0.710).

Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer

ATLAS Signals

ATLAS Signals, every week

The week in the market, three stocks on ATLAS’s radar and what comes next. Get it every Monday.

By subscribing you agree to receive ATLAS Signals by email every Monday. You can unsubscribe with one click at any time. Privacy